Stock MARKSANS MARKSANS PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Marksans Pharma Limited Bombay S.E.

Equities

MARKSANS

INE750C01026

Delayed Bombay S.E.
Other stock markets
 02:09:58 2024-04-29 am EDT 		5-day change 1st Jan Change
170.4 INR -1.02% Intraday chart for Marksans Pharma Limited +1.67% +6.09%
Apr. 18 Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA MT
Feb. 14 Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024

Evolution of the average Target Price on Marksans Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

aaffdb84465.yqTM9nggmnm4DVL3SIPpSkKTTiGECb7bBbdX4pk5jF0.u-K_lxJR8RHSaBTafuGZJhWmK1XdP46IYc0-ivcJ-DSs9o-jSFjXT4tHYg~c97fa992b24bbfa42e00b1c4f1ce99d4

Analyst Recommendations on Marksans Pharma Limited

CARE Affirms A+ Rating on Marksans Pharma's Long-term Bank Financing; Outlook Stable MT
CARE Keeps A+ Rating on Marksans Pharma's Fund-based Bank Financing; Lowers Outlook to Stable MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
172.2
Average target price
-

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MARKSANS Stock
  4. MARKSANS Stock
  5. Consensus Marksans Pharma Limited